evidence: Viral load gradually returned to baseline levels in the following weeks, with no differences between the LPS and placebo pretreatment groups.
intervention: Escherichia coli-derived lipopolysaccharide (LPS), 2 ng/kg
comparator: placebo
outcome: seroconversion